Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
INCYTE RG (NQ: INCY)
70.11 USD  UNCHANGED
Official Closing Price  /  Updated: 8:00 PM EDT, Jul 16, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,139,453
Open 69.93
Bid (Size) 61.50 (100)
Ask (Size) 75.00 (100)
Prev. Close 70.11
Today's Range 69.73 - 70.95
52wk Range 60.23 - 140.11
Shares Outstanding 211,969,163
Dividend Yield N/A
Performance
YTD
-30.51%
-30.51%
1 Month
-2.65%
-2.65%
3 Month
-0.37%
-0.37%
6 Month
-23.50%
-23.50%
1 Year
-46.33%
-46.33%
Featured News
More News
Here are Friday’s worst stocks as trade conflict and a weak jobs report disappoint investors
Dow industrials led the market lower, with Caterpillar, Intel and Boeing all down more than 3%. Read More
category NKE , DWDP , JPM , and 65 more.
from MarketWatch
As stocks recover, Goldman sees ‘lowered bar’ for volatility’s return
The U.S. stock market has largely recovered since the correction it suffered in early February, but those gains could mean investors are failing to appreciate the potential for volatility returning to... Read More
category INCY , SPX , Pharmaceuticals , and 11 more.
from MarketWatch
Featured News
Read More
In the bull market’s ninth year, ‘winning’ stocks hide lingering pain
category XOM , WYN , ETFC , and 73 more.
from MarketWatch
Five biotech buyout candidates you should look at right now
category IBB , Opinion , Medical Products , and 15 more.
from MarketWatch
Biggest Nasdaq winners and losers in 2017: Chip makers, videogame publishers lead tech
category S , MU , ORLY , and 40 more.
from MarketWatch
Why 2018 is a make-or-break year for pharma
category Pharmaceuticals , SRPT , XPH , and 17 more.
from MarketWatch
Analysts expect these large-cap U.S. stocks to rise at least 25% in 2018
category FB , GILD , ATVI , and 48 more.
from MarketWatch
Six promising stocks to buy when the biotech correction ends
category AZN , LLY , ALXN , and 22 more.
from MarketWatch
More News
Read More
Incyte to Report Second Quarter Financial Results
from Business Wire News Releases
Benzinga's Bulls & Bears Of The Week: AT&T, Facebook, Intel, Netflix, Twitter And More
category Market News , INCY , KDP , and 12 more.
from Benzinga
Incyte Has Limited Catalysts In Next 6 Months; But 2019 Could Be Pivotal, Morgan Stanley Says In Downgrade
category Biotech , Price Target , Analyst Ratings , and 8 more.
from Benzinga
The Market In 5 Minutes: AT&T-Time Warner Appeal, Johnson & Johnson Lawsuit, Theresa May And More
category NFLX , Markets , INCY , and 13 more.
from Benzinga
First Week of INCY August 17th Options Trading
category Stocks
from Market News Video
Analysts Expect EQWM To Hit $55
category ETFs
from ETF Channel
Incyte to Present Diversified Development Portfolio and Opportunities for Accelerated Growth at 2018 Investor and Analyst Event
from Business Wire News Releases
Benzinga's Bulls & Bears Of The Week: Amazon, GE, Intel, T-Mobile And More
category Media , MAT , KR , and 21 more.
from Benzinga
Incyte Announces REACH1 Pivotal Trial Meets Primary Endpoint of Overall Response Rate for Ruxolitinib (Jakafi®) in Steroid-Refractory Acute Graft-Versus-Host Disease
from Business Wire News Releases
A 2018 Midyear Update: The 10 Worst-Performing S&P 500 Stocks
category ALB , SYMC , INCY , and 13 more.
from Benzinga
Tuesday Sector Laggards: Financial, Healthcare
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

WHAT'S POPULAR IN THE VILLE